Super V3 Investment Limited Partnership Jafco, 10% Owner at Tracon Pharmaceuticals, Inc. (TCON), sold 24,300 shares at $10.71 ($257K) on 2015-09-09, disclosed to the SEC on 2015-09-09.
Open-market sale of $257k TCON by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.48 | 6,600 | $69K | 26.9% |
| 2 | $10.47 | 5,700 | $60K | 23.2% |
| 3 | $10.71 | 12,000 | $129K | 49.9% |
| Total | $10.59 avg | 24,300 | $257K | 100% |
| Filing → |
| TCON | SELL | 2015-10-13 | $32K | — | Filing → |
| TCON | SELL | 2015-10-08 | $221K | — | Filing → |
| TCON | SELL | 2015-10-06 | $152K | — | Filing → |